Reported Tuberculosis in the United States, 2016

Related Pages

PDF pdf icon[12MB]

Surveillance Report

Surveillance Data Training: Report of Verified Case of Tuberculosis

NOTE: Click the links below to show or hide the tables for each section.

  • Table 1. Tuberculosis Cases, Case Rates per 100,000 Population, Deaths, and Death Rates per 100,000 Population, and Percent Change: United States, 1953–2016 pdf icon[PDF – 222 KB]
  • Table 2. Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Hispanic Ethnicity and Non-Hispanic Race: United States, 1993–2016 pdf icon[PDF – 393 KB]
  • Table 3. Tuberculosis Cases and Percentages by Hispanic Ethnicity and Non-Hispanic Race, and by Origin of Birth: United States, 1993–2016 pdf icon[PDF – 482 KB]
  • Table 4. Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Age Group: United States, 1993–2016 pdf icon[PDF – 443 KB]
  • Table 5. Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Origin of Birth: United States, 1993–2016 pdf icon[PDF – 203 KB]
  • Table 6. Tuberculosis Cases and Percentages Among Non-U.S.–Born Persons by the Top 30 Countries of Birth: United States, 2012–2016 pdf icon[PDF – 322 KB]
  • Table 7. Tuberculosis Cases and Percentages by Case Verification Criterion and Site of Disease: United States, 1993–2016 pdf icon[PDF – 360 KB]
  • Table 8. Tuberculosis Cases and Percentages, by Resistance to Isoniazid (INH), Origin of Birth, and Previous History of TB: United States, 1993–2016 pdf icon[PDF – 339 KB]
  • Table 9. Tuberculosis Cases and Percentages, by Multidrug Resistance (MDR), Origin of Birth, and Previous History of TB: United States, 1993–2016 pdf icon[PDF – 216 KB]
  • Table 10. Percentages of Tuberculosis Cases, by Initial Drug Regimen, Use of Directly Observed Therapy (DOT), and Completion of Therapy (COT): United States, 1993–2016 pdf icon[PDF – 202 KB]
  • Table 11. Tuberculosis Cases and Percentages Among Persons with HIV Test Results and with HIV Coinfection, by Age Group: United States, 1993–2016 pdf icon[PDF – 428 KB]
  • Table 12. Tuberculosis Cases and Percentages, by Reason Tuberculosis Therapy Was Stopped: United States, 1993–2014 pdf icon[PDF – 429 KB]
  • Table 13. National Tuberculosis Genotyping Surveillance Coverage: United States, 2004–2016 pdf icon[PDF – 239 KB]
  • Table 14. National Tuberculosis Genotyping Surveillance Coverage: United States-Affiliated Areas, 2004–2016 pdf icon[PDF – 233 KB]
  • Table 15. Genotyped Tuberculosis Cases with Mycobacterium bovis by Origin of Birth: United States, 2004–2016  pdf icon[PDF – 250 KB]
  • Table 16. Tuberculosis Cases and Percentages Among Non-U.S.–Born Persons, by the Top 30 Countries of Birth and Years in the United States Before TB Diagnosis: United States, 2016  pdf icon[PDF – 534 KB]
  • Table 17. Tuberculosis Cases and Rates per 100,000 Population, by Hispanic Ethnicity and Non-Hispanic Race, Sex, and Age Group: United States, 2016  pdf icon[PDF – 340 KB]
  • Table 18. Tuberculosis Cases Among U.S.-Born Persons, by Hispanic Ethnicity and Non-Hispanic Race, Sex, and Age Group: United States, 2016  pdf icon[PDF – 221 KB]
  • Table 19. Tuberculosis Cases Among Non-U.S.–Born Persons, by Hispanic Ethnicity and Non-Hispanic Race, Sex, and Age Group: United States, 2016  pdf icon[PDF – 223 KB]
  • Table 20. Tuberculosis Cases Among Non-U.S.–Born Persons, by WHO Region and Country of Birth: United States, 2016  pdf icon[PDF – 271 KB]
  • Table 21. Tuberculosis Risk Factors, by Origin and Race/Ethnicity: United States, 2016  pdf icon[PDF – 262 KB]
  • Table 22. Characteristics of Tuberculosis Cases in GENType Clusters, by Alert Levels Based on Log-Likelihood Ratios (LLR): United States, 2014–2016  pdf icon[PDF – 583 KB]
  • Table 23. Tuberculosis Cases and Clusters, by Cluster Size: United States, 2014–2016  pdf icon[PDF – 234 KB]
  • Table 24. Twenty-Five Most Frequently Reported GENTypes Among Genotyped Tuberculosis Cases: United States, 2014–2016  pdf icon[PDF – 259 KB]
  • Table 25. Five Most Frequently Reported GENTypes Among Genotyped Tuberculosis Cases: United States-Affiliated Areas, 2014–2016  pdf icon[PDF – 208 KB]
  • Table 29. Tuberculosis Cases and Case Rates per 100,000 Population: Reporting Areas, 2016 and 2015 pdf icon[PDF – 263 KB]
  • Table 30. Tuberculosis Cases and Case Rates per 100,000 Population, Ranked and Grouped by Number of Cases: United States and the District of Columbia, 2016 and 2015 pdf icon[PDF – 245 KB]
  • Table 31. Tuberculosis Cases and Percentages, by Age Group: Reporting Areas, 2016 pdf icon[PDF – 543 KB]
  • Table 32. Tuberculosis Cases and Percentages by Hispanic Ethnicity and Non-Hispanic Race: Reporting Areas, 2016 pdf icon[PDF – 516 KB]
  • Table 33. Tuberculosis Cases and Percentages, U.S.-Born and Non-U.S.–Born Persons: Reporting Areas, 2016 pdf icon[PDF – 229 KB]
  • Table 34. Tuberculosis Cases and Percentages Among Non-U.S.–Born Persons, by Top Seven Countries of Birth: Reporting Areas, 2016 pdf icon[PDF – 364 KB]
  • Table 35. Tuberculosis Cases and Percentages Among Non-U.S.–Born Persons, by Immigration Status at First Entry: Reporting Areas, 2016 pdf icon[PDF – 475 KB]
  • Table 36. Tuberculosis Cases and Percentages Among Non-U.S.–Born Persons, by Number of Years in the United States: Reporting Areas, 2016 pdf icon[PDF – 414 KB]
  • Table 37. Tuberculosis Cases and Percentages, by Pulmonary and Extrapulmonary Disease: Reporting Areas, 2016 pdf icon[PDF – 326 KB]
  • Table 38. Extrapulmonary Tuberculosis Cases and Percentages by Site of Disease: Reporting Areas, 2016 pdf icon[PDF – 292 KB]
  • Table 39. Tuberculosis Risk Factors: Reporting Areas, 2016 pdf icon[PDF – 587 KB]
  • Table 40. Primary Reason for Tuberculosis Evaluation: Reporting Areas, 2016 pdf icon[PDF – 551 KB]
  • Table 41. Tuberculosis Cases and Percentages, by Residence in and Type of Correctional Facilities, Ages ≥15 Years: Reporting Areas, 2016 pdf icon[PDF – 381 KB]
  • Table 42. Tuberculosis Cases and Percentages, by Homeless Status, Ages ≥15 Years: Reporting Areas, 2016 pdf icon[PDF – 231 KB]
  • Table 43. Tuberculosis Cases and Percentages, by Residence in Long–Term Care Facilities, Ages ≥15 Years: Reporting Areas, 2016 pdf icon[PDF – 234 KB]
  • Table 44. Tuberculosis Cases and Percentages, by Injecting Drug Use, Ages ≥15 Years: Reporting Areas, 2016 pdf icon[PDF – 210 KB]
  • Table 45. Tuberculosis Cases and Percentages, by Noninjecting Drug Use, Ages ≥15 Years: Reporting Areas, 2016 pdf icon[PDF – 211 KB]
  • Table 46. Tuberculosis Cases and Percentages, by Excess Alcohol Use, Ages ≥15 Years: Reporting Areas, 2016 pdf icon[PDF – 211 KB]
  • Table 47. Tuberculosis Cases and Percentages by Primary Occupation, Ages ≥15 Years: Reporting Areas, 2016 pdf icon[PDF – 225 KB]
  • Table 48. Tuberculosis Cases and Percentages, by Initial Drug Regimen: Reporting Areas, 2016 pdf icon[PDF – 217 KB]
  • Table 49. Culture-Positive Tuberculosis Cases and Percentages with Drug Susceptibility Results, by Resistance to Isoniazid or Multidrug Resistance: Reporting Areas, 2016 pdf icon[PDF – 217 KB]
  • Table 50. Tuberculosis Cases and Percentages, by HIV Status: Reporting Areas, 2016 pdf icon[PDF – 217 KB]
  • Table 51. Tuberculosis Diagnostic Tests, by Type of Laboratory: Reporting Areas, 2016 pdf icon[PDF – 248 KB]
  • Table 52. Tuberculosis Genotyping Surveillance Coverage: Reporting Areas, 2016 pdf icon[PDF – 208 KB]
  • Table 53. Tuberculosis Cases and Percentages, by Type of Health Care Provider: Reporting Areas, 2014 pdf icon[PDF – 217 KB]
  • Table 54. Tuberculosis Cases and Percentages, by Directly Observed Therapy (DOT): Reporting Areas, 2014 pdf icon[PDF – 214 KB]
  • Table 55. Tuberculosis Cases and Percentages, by Reason Therapy Was Stopped: Reporting Areas, 2014 pdf icon[PDF – 240 KB]
  • Table 56. Reason Therapy Was Extended Beyond 12 Months: Reporting Areas, 2014 pdf icon[PDF – 240 KB]
  • Table 57. Completion of Tuberculosis Therapy (COT) Cases and Percentages, by Hispanic Ethnicity and Non-Hispanic Race: Reporting Areas, 2014 pdf icon[PDF – 254 KB]
  • Table 58. Tuberculosis Cases and Percentages, by Completion of Tuberculosis Therapy (COT): Reporting Areas, 2014 pdf icon[PDF – 216 KB]
  • Table 59. Tuberculosis Cases and Percentages Among Persons Completing Therapy for Whom Therapy Was Indicated for ≤1 Year: Reporting Areas, 2010–2014 pdf icon[PDF – 227 KB]
  • Table 60. Tuberculosis Cases and Case Rates per 100,000 Population: Metropolitan Statistical Areas with ≥500,000 Population, 2016 and 2015 pdf icon[PDF – 392 KB]
  • Table 61. Tuberculosis Cases, by Age Group: Metropolitan Statistical Areas with ≥500,000 Population, 2016 pdf icon[PDF – 502 KB]
  • Table 62. Tuberculosis Cases, by Hispanic Ethnicity and Non-Hispanic Race: Metropolitan Statistical Areas with ≥500,000 Population, 2016 pdf icon[PDF – 251 KB]
  • Table 63. Tuberculosis Cases and Percentages, U.S.-Born Persons and Non-U.S.–Born Persons: Metropolitan Statistical Areas with ≥500,000 Population, 2016 pdf icon[PDF – 280 KB]
  • Table 64. Tuberculosis Cases and Percentages, by Homeless Status, Ages ≥15 Years: Metropolitan Statistical Areas with ≥500,000 Population, 2016 pdf icon[PDF – 261 KB]

Notes on Recent Transmission pdf icon[PDF – 273 KB]

Figures

  • Figure 1. Estimated Cases Attributed to Recent Transmission of Tuberculosis, United States, 2015–2016 image icon[JPG – 388 KB]
  • Figure 2. Estimated Percentage of Extensive Recent Transmission of Tuberculosis in Counties with ≥10 Genotyped Cases, United States, 2015–2016 image icon[JPG – 276 KB]

Tables

  • Table 65. Counts and Percentages of Tuberculosis Cases Estimated to be Attributed to Overall and Extensive Recent Transmission: Reporting Areas, 2015–2016 pdf icon[PDF – 233 KB]
  • Table 66. Counts and Percentages of Tuberculosis Cases Estimated to be Attributed to Overall and Extensive Recent Transmission: Counties with >5 Percent Estimated Extensive Recent Transmission, 2015-2016 pdf icon[PDF – 201 KB]
  • Table 67. Characteristics of Tuberculosis Cases Estimated to be Attributed to Overall and Extensive Recent Transmission: United States, 2015–2016 pdf icon[PDF – 264 KB]
Page last reviewed: November 16, 2017
Content source: Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention